Africa Energy
CVE:AFEAfrica Energy Corp. operates as an oil and gas exploration and production company in South Africa and Namibia. The company focuses on potential gas condensate development on Block 11B/12B offshore in South Africa. It holds interest in the Block 2B offshore the Republic of South Africa. The company was formerly known as Horn Petroleum Corporation and changed its name to Africa Energy Corp. in March 2015. Africa Energy Corp. is headquartered in Vancouver, Canada.
Evolution Petroleum
NYSEAMERICAN:EPMEvolution Petroleum Corporation, an energy company, engages in the development, production, ownership, and exploitation of onshore oil and gas properties in the United States. The company holds interests in a CO2 enhanced oil recovery project in Louisiana's Delhi field. Its Delhi Holt-Bryant Unit covers an area of approximately 13,636 acres located in Northeast Louisiana. The company also holds interests in the Hamilton Dome field covering 5,908 acres located in Hot Springs County, Wyoming; Barnett Shale field covering an area of 123,777 acres located in North Texas; Williston Basin covering an area of 145,743 acres located in North Dakota; Jonah Field covering an area of 5,280 acres located in Sublette County, Wyoming; and small overriding royalty interests in four onshore central Texas wells. Evolution Petroleum Corporation was founded in 2003 and is based in Houston, Texas.
Pharming Group
NASDAQ:PHARPharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.
Storm Resources
TSE:SRXStorm Resources Ltd. operates as a crude oil and natural gas exploration and development company in Canada. The company primarily owns interests in lands covering an area of 120,000 net acres located in Umbach, Nig Creek, and Fireweed areas of Northeast British Columbia. As of December 31, 2020, it had 49,134 thousand barrels of oil equivalent of total proved plus probable reserves. Storm Resources Ltd. was incorporated in 2010 and is headquartered in Calgary, Canada.